PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribersm5thmEditionmWoomRobinsonmTest mBank
Chapterm1.mThemRolemof mthemNursemPractitioner
m MultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersmthemquestion.
m 1.mNursempractitionermprescriptivemauthoritymismregulated m by:
1. ThemNationalmCouncilmof mStatemBoardsmof mNursing
2. ThemU.S.mDrugmEnforcement mAdministration
3. ThemStatemBoard mof mNursingmformeachmstate
4. ThemStatemBoard mof mPharmacy
m 2.mThembenefitsmtomthempatient mof mhavingmanmAdvanced mPracticemRegistered mNursem(APRN)mprescri
berminclude:
1. Nursesmknowmmoremabout mPharmacologymthanmothermprescribersmbecausemtheymtake
mit mbothminmtheirmbasicmnursingmprogrammand minmtheir mAPRN mprogram.
2. Nursesmcaremformthempatient mfrommamholisticmapproachmand mincludemthempatient min
decisionmmakingmregardingmtheirmcare.
3. APRNsmaremlessmlikelymtomprescribemnarcoticsmand mothermcontrolled msubstances.
4. APRNsmaremablemtomprescribemindependentlyminmallmstates,mwhereasmamphysician
’smassistant mneedsmtomhavemamphysicianmsupervisingmtheirmpractice.
m 3.mClinicalmjudgment minmprescribingm includes:
1. Factoringminmthemcost mtomthempatient mof mthemmedicationmprescribed
2. Alwaysmprescribingmthemnewest mmedicationmavailablemformthemdiseasemprocess
3. Handingmout mdrugmsamplesmtompoormpatients
4. Prescribingmallmgenericmmedicationsmtomcut mcosts
m 4.mCriteriamformchoosingmanmeffectivemdrugmformamdisorderm include:
1. Askingmthempatient mwhat mdrugmtheymthinkmwould mworkmbest mformthem
2. Consultingmnationallymrecognized mguidelinesmformdiseasemmanagement
3. Prescribingmmedicationsmthat maremavailablemasmsamplesmbeforemwritingmamprescription
4. FollowingmU.S.mDrugmEnforcement mAdministrationmguidelinesmformprescribing
m 5.mNursempractitionermpracticemmaymthrivemundermhealth-caremreformmbecausem of:
1. Themdemonstrated mabilitymof mnursempractitionersmtomcontrolmcostsmand mimprovempatie
nt moutcomes
2. Themfact mthat mnursempractitionersmwillmbemablemtompracticemindependently
3. Themfact mthat mnursempractitionersmwillmhavemfullmreimbursement mundermhealth-
caremreform
4. Themabilitymtomshift maccountabilitymformMedicaid mtomthemstatemlevel
,PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
, PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
Chapterm1.mThemRolemof mthemNursemPractitioner
mAnswermSection
MULTIPLEmCHOICE
1. ANS:m m 3 PTS:m 1
2. ANS:m m 2 PTS:m 1
3. ANS:m m 1 PTS:m 1
4. ANS:m m 2 PTS:m 1
5. ANS:m m 1 PTS:m 1
Chapterm2.mReview mof mBasicmPrinciplesmof mPharmacologymM
ultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersmthemquestion.
m 1.mA mpatient’smnutritionalmintakemand mlaboratorymresultsmreflect mhypoalbuminemia.mThismismcritical
mtomprescribingmbecause:
1. Distributionmof mdrugsmtomtarget mtissuemmaymbemaffected.
2. Themsolubilitymof mthemdrugmwillmnot mmatchmthemsitemof mabsorption.
3. Theremwillmbemlessmfreemdrugmavailablemtomgeneratemanmeffect.
4. Drugsmbound mtomalbuminmaremreadilymexcreted mbymthemkidneys.
m 2.mDrugsmthat mhavemamsignificant mfirst-passm effect:
1. Must mbemgivenmbymthementeralm(oral)mroutemonly
2. Bypassmthemhepaticmcirculation
3. Aremrapidlymmetabolized mbymthemlivermand mmaymhavemlittlemif manymdesired maction
4. Aremconverted mbymthemlivermtommoremactivemand mfat-solublemforms
m 3.mThemroutemof mexcretionmof mamvolatilemdrugmwillmlikelymbem the:
1. Kidneys
2. Lungs
3. Bilemand mfeces
4. Skin
m 4.mMedroxyprogesteronem(DepomProvera)mismprescribed mintramuscularlym(IM)mtomcreatemamstora
gemreservoirmof mthemdrug.mStoragemreservoirs:
1. Assuremthat mthemdrugmwillmreachmitsmintended mtarget mtissue
2. Aremthemreasonmformgivingmloadingmdoses
3. Increasemthemlengthmof mtimemamdrugmismavailablemand mactive
4. Aremmost mcommonminmcollagenmtissues
m 5.mThemNPmchoosesmtomgivemcephalexinmeverym8mhoursmbased monmknowledgemof mthem drug’s:
1. Propensitymtomgomtomthemtarget mreceptor
2. Biologicalmhalf-life
3. Pharmacodynamics
4. Safetymand msidemeffects
, PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
m 6.mAzithromycinmdosingmrequiresmthat mthemfirst mday’smdosagembemtwicemthosemof mthemotherm4mdaysmofm
themprescription.mThismismconsidered mamloadingmdose.mAmloadingmdose:
1. Rapidlymachievesmdrugmlevelsminmthemtherapeuticmrange
2. Requiresmfour-mtomfive-half-livesmtomattain
3. Isminfluenced mbymrenalmfunction
4. Ismdirectlymrelated mtomthemdrugmcirculatingmtomthemtarget mtissues
m 7.mThempoint minmtimemonmthemdrugmconcentrationmcurvemthat mindicatesmthemfirst msignmof mamtherapeuticmef
fect mismthe:
1. Minimummadversemeffect mlevel
2. Peakmof maction
Bank
PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribersm5thmEditionmWoomRobinsonmTest mBank
Chapterm1.mThemRolemof mthemNursemPractitioner
m MultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersmthemquestion.
m 1.mNursempractitionermprescriptivemauthoritymismregulated m by:
1. ThemNationalmCouncilmof mStatemBoardsmof mNursing
2. ThemU.S.mDrugmEnforcement mAdministration
3. ThemStatemBoard mof mNursingmformeachmstate
4. ThemStatemBoard mof mPharmacy
m 2.mThembenefitsmtomthempatient mof mhavingmanmAdvanced mPracticemRegistered mNursem(APRN)mprescri
berminclude:
1. Nursesmknowmmoremabout mPharmacologymthanmothermprescribersmbecausemtheymtake
mit mbothminmtheirmbasicmnursingmprogrammand minmtheir mAPRN mprogram.
2. Nursesmcaremformthempatient mfrommamholisticmapproachmand mincludemthempatient min
decisionmmakingmregardingmtheirmcare.
3. APRNsmaremlessmlikelymtomprescribemnarcoticsmand mothermcontrolled msubstances.
4. APRNsmaremablemtomprescribemindependentlyminmallmstates,mwhereasmamphysician
’smassistant mneedsmtomhavemamphysicianmsupervisingmtheirmpractice.
m 3.mClinicalmjudgment minmprescribingm includes:
1. Factoringminmthemcost mtomthempatient mof mthemmedicationmprescribed
2. Alwaysmprescribingmthemnewest mmedicationmavailablemformthemdiseasemprocess
3. Handingmout mdrugmsamplesmtompoormpatients
4. Prescribingmallmgenericmmedicationsmtomcut mcosts
m 4.mCriteriamformchoosingmanmeffectivemdrugmformamdisorderm include:
1. Askingmthempatient mwhat mdrugmtheymthinkmwould mworkmbest mformthem
2. Consultingmnationallymrecognized mguidelinesmformdiseasemmanagement
3. Prescribingmmedicationsmthat maremavailablemasmsamplesmbeforemwritingmamprescription
4. FollowingmU.S.mDrugmEnforcement mAdministrationmguidelinesmformprescribing
m 5.mNursempractitionermpracticemmaymthrivemundermhealth-caremreformmbecausem of:
1. Themdemonstrated mabilitymof mnursempractitionersmtomcontrolmcostsmand mimprovempatie
nt moutcomes
2. Themfact mthat mnursempractitionersmwillmbemablemtompracticemindependently
3. Themfact mthat mnursempractitionersmwillmhavemfullmreimbursement mundermhealth-
caremreform
4. Themabilitymtomshift maccountabilitymformMedicaid mtomthemstatemlevel
,PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
, PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
Chapterm1.mThemRolemof mthemNursemPractitioner
mAnswermSection
MULTIPLEmCHOICE
1. ANS:m m 3 PTS:m 1
2. ANS:m m 2 PTS:m 1
3. ANS:m m 1 PTS:m 1
4. ANS:m m 2 PTS:m 1
5. ANS:m m 1 PTS:m 1
Chapterm2.mReview mof mBasicmPrinciplesmof mPharmacologymM
ultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersmthemquestion.
m 1.mA mpatient’smnutritionalmintakemand mlaboratorymresultsmreflect mhypoalbuminemia.mThismismcritical
mtomprescribingmbecause:
1. Distributionmof mdrugsmtomtarget mtissuemmaymbemaffected.
2. Themsolubilitymof mthemdrugmwillmnot mmatchmthemsitemof mabsorption.
3. Theremwillmbemlessmfreemdrugmavailablemtomgeneratemanmeffect.
4. Drugsmbound mtomalbuminmaremreadilymexcreted mbymthemkidneys.
m 2.mDrugsmthat mhavemamsignificant mfirst-passm effect:
1. Must mbemgivenmbymthementeralm(oral)mroutemonly
2. Bypassmthemhepaticmcirculation
3. Aremrapidlymmetabolized mbymthemlivermand mmaymhavemlittlemif manymdesired maction
4. Aremconverted mbymthemlivermtommoremactivemand mfat-solublemforms
m 3.mThemroutemof mexcretionmof mamvolatilemdrugmwillmlikelymbem the:
1. Kidneys
2. Lungs
3. Bilemand mfeces
4. Skin
m 4.mMedroxyprogesteronem(DepomProvera)mismprescribed mintramuscularlym(IM)mtomcreatemamstora
gemreservoirmof mthemdrug.mStoragemreservoirs:
1. Assuremthat mthemdrugmwillmreachmitsmintended mtarget mtissue
2. Aremthemreasonmformgivingmloadingmdoses
3. Increasemthemlengthmof mtimemamdrugmismavailablemand mactive
4. Aremmost mcommonminmcollagenmtissues
m 5.mThemNPmchoosesmtomgivemcephalexinmeverym8mhoursmbased monmknowledgemof mthem drug’s:
1. Propensitymtomgomtomthemtarget mreceptor
2. Biologicalmhalf-life
3. Pharmacodynamics
4. Safetymand msidemeffects
, PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribers m5thmEditionmWoo mRobinsonmTestm
Bank
m 6.mAzithromycinmdosingmrequiresmthat mthemfirst mday’smdosagembemtwicemthosemof mthemotherm4mdaysmofm
themprescription.mThismismconsidered mamloadingmdose.mAmloadingmdose:
1. Rapidlymachievesmdrugmlevelsminmthemtherapeuticmrange
2. Requiresmfour-mtomfive-half-livesmtomattain
3. Isminfluenced mbymrenalmfunction
4. Ismdirectlymrelated mtomthemdrugmcirculatingmtomthemtarget mtissues
m 7.mThempoint minmtimemonmthemdrugmconcentrationmcurvemthat mindicatesmthemfirst msignmof mamtherapeuticmef
fect mismthe:
1. Minimummadversemeffect mlevel
2. Peakmof maction
